In consequence of these studies, assessment of CACHD1+ foci as an early marker of preneoplastic lesions in STAM mice NASH model could become a useful tool to analyze the effects of various potential NASH and tumor inhibitors and promoters in both short- and long-term studies. This evidence concerns the gene CACHD1 and metabolic dysfunction-associated steatohepatitis.